Helmholtz Zentrum München
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 1K
- Market Cap
- -
Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity
Not Applicable
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: B. infantis
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 1149
- Registration Number
- NCT04769037
- Locations
- 🇧🇪
University Hospitals Leuven Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium
🇩🇪Universitätsklinikum Carl Gustav Carus Technische Universität Dresden, Dresden, Germany
🇩🇪AUF DER BULT, Kinder- und Jugendkrankenhaus, Hannover, Germany
Fr1da Early Diagnosis and Care of Type 1 Diabetes
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 285000
- Registration Number
- NCT04039945
- Locations
- 🇩🇪
Institut für Diabetesforschung, Helmholtz Zentrum München, Munich, Germany
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Recruiting
- Conditions
- Identification of Infants at Risk for Type 1 Diabetes
- First Posted Date
- 2017-10-20
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 1000000
- Registration Number
- NCT03316261
- Locations
- 🇩🇪
Institut für Diabetesforschung, Helmholtz Zentrum München, Munich, Germany
© Copyright 2025. All Rights Reserved by MedPath